Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.
Zeyen T, Böhm L, Paech D, Schäfer N, Tzaridis T, Duffy C, Nitsch L, Schneider M, Potthoff AL, Schneider-Rothhaar JL, Steinbach JP, Hau P, Kowalski T, Seidel C, Krex D, Grauer O, Goldbrunner R, Zeiner PS, Tabatabai G, Galldiks N, Stummer W, Hattingen E, Glas M, Gkika E, Vatter H, Radbruch A, Herrlinger U, Weller J, Schaub C. Zeyen T, et al. Among authors: schaub c. Neuro Oncol. 2024 Oct 1:noae205. doi: 10.1093/neuonc/noae205. Online ahead of print. Neuro Oncol. 2024. PMID: 39351820
Transient MRI changes and neurological deterioration in glioblastoma upon SARS-CoV-2 infection.
Zeyen T, Friker LL, Paech D, Schaefer N, Weller J, Zschernack V, Layer JP, Schneider M, Potthoff AL, Bernhardt M, Sanders C, Kristiansen G, Hoelzel M, Gkika E, Radbruch A, Pietsch T, Herrlinger U, Schaub C. Zeyen T, et al. Among authors: schaub c. J Cancer Res Clin Oncol. 2024 Sep 28;150(9):437. doi: 10.1007/s00432-024-05963-4. J Cancer Res Clin Oncol. 2024. PMID: 39340558 Free PMC article.
Current status of precision oncology in adult glioblastoma.
Weller J, Potthoff AL, Zeyen T, Schaub C, Duffy C, Schneider M, Herrlinger U. Weller J, et al. Among authors: schaub c. Mol Oncol. 2024 Dec;18(12):2927-2950. doi: 10.1002/1878-0261.13678. Epub 2024 Jun 20. Mol Oncol. 2024. PMID: 38899374 Free PMC article. Review.
FH-mutant glioma displaying the epigenetic signature of IDH-mutant astrocytomas.
Zschernack V, Thomas C, Schaub C, Kristiansen G, Waha A, Goschzik T, Herrlinger U, Pietsch T. Zschernack V, et al. Among authors: schaub c. J Neuropathol Exp Neurol. 2024 Oct 1;83(10):887-889. doi: 10.1093/jnen/nlae064. J Neuropathol Exp Neurol. 2024. PMID: 38874462 No abstract available.
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial.
Giordano FA, Layer JP, Leonardelli S, Friker LL, Turiello R, Corvino D, Zeyen T, Schaub C, Müller W, Sperk E, Schmeel LC, Sahm K, Oster C, Kebir S, Hambsch P, Pietsch T, Bisdas S, Platten M, Glas M, Seidel C, Herrlinger U, Hölzel M. Giordano FA, et al. Among authors: schaub c. Nat Commun. 2024 May 28;15(1):4210. doi: 10.1038/s41467-024-48416-9. Nat Commun. 2024. PMID: 38806504 Free PMC article. Clinical Trial.
183 results